Fibrocell Science, Inc.
DelistedCIK 357097fmd_1CWEZE79JFV9Z594NMPFTNGM6RManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2004 to Sep 30, 2019, 40 periods
Latest annual · FY2018
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (12)
- Net income
- (10)
- Free cash flow
- (13)
Latest quarter · Q3 FY2019
Millions- Total revenues
- 1
- Gross profit
- (1)
- Operating income
- (4)
- Net income
- (7)
- Free cash flow
- (7)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2015 to FY2018
- n/m
- Revenue, 5 yearsFY2013 to FY2018
- n/m
- Net income, 5 yearsFY2013 to FY2018
- n/m
Fibrocell Science, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2018 | FY2017 | Change | Source |
|---|---|---|---|---|
| Revenue | $0 | $0 | 10-K 2019-03-27 · proof | |
| Operating income | -$12.4 million | -$19 million | 10-K 2019-03-27 · proof | |
| Net income | -$10.3 million | -$16.2 million | 10-K 2019-03-27 · proof | |
| Cash from operating activities | -$12.7 million | -$17 million | 10-K 2019-03-27 · proof | |
| Free cash flow | -$12.9 million | -$17.5 million | 10-K 2019-03-27 · proof | |
| Total assets | $15.8 million | $19.4 million | -18.8% | 10-K 2019-03-27 · proof |
| Total liabilities | $6.2 million | $10.4 million | -40.4% | 10-K 2019-03-27 · proof |
| Cash and cash equivalents | $14.4 million | $17.4 million | -17.1% | 10-K 2019-03-27 · proof |
- What was Fibrocell Science, Inc.'s revenue in fiscal 2018?
- Fibrocell Science, Inc. reported revenue of $0 for fiscal 2018 (the year ended Dec 31, 2018), against $0 the year before. Source: the 10-K filed with the SEC on Mar 27, 2019. SEC
- What was Fibrocell Science, Inc.'s operating income in fiscal 2018?
- Fibrocell Science, Inc. reported operating income of -$12.4 million for fiscal 2018 (the year ended Dec 31, 2018), against -$19 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2019. SEC
- What was Fibrocell Science, Inc.'s net income in fiscal 2018?
- Fibrocell Science, Inc. reported net income of -$10.3 million for fiscal 2018 (the year ended Dec 31, 2018), against -$16.2 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2019. SEC
- What was Fibrocell Science, Inc.'s cash from operating activities in fiscal 2018?
- Fibrocell Science, Inc. reported cash from operating activities of -$12.7 million for fiscal 2018 (the year ended Dec 31, 2018), against -$17 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2019. SEC
- What was Fibrocell Science, Inc.'s free cash flow in fiscal 2018?
- Fibrocell Science, Inc. reported free cash flow of -$12.9 million for fiscal 2018 (the year ended Dec 31, 2018), against -$17.5 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2019. SEC
- What are Fibrocell Science, Inc.'s total assets?
- As of Dec 31, 2018, Fibrocell Science, Inc. reported total assets of $15.8 million, against $19.4 million a year earlier (-18.8%). Source: the 10-K filed with the SEC on Mar 27, 2019. SEC
- What are Fibrocell Science, Inc.'s total liabilities?
- As of Dec 31, 2018, Fibrocell Science, Inc. reported total liabilities of $6.2 million, against $10.4 million a year earlier (-40.4%). Source: the 10-K filed with the SEC on Mar 27, 2019. SEC
- What are Fibrocell Science, Inc.'s cash and cash equivalents?
- As of Dec 31, 2018, Fibrocell Science, Inc. reported cash and cash equivalents of $14.4 million, against $17.4 million a year earlier (-17.1%). Source: the 10-K filed with the SEC on Mar 27, 2019. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:357097&period_type=annual&limit=5"Information only, not investment advice.